Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 2007919 · INBX

Inhibrx Biosciences, Inc.

Filing with the SEC SEC-reporting company La Jolla, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $140M for the year (2024: $1.69B).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$1.3M$200K
Net income (loss)−$140M$1.69B
Total assets$146M$181M
Total liabilities$138M$47.2M
Stockholders’ equity$8M$134M
Cash and equivalents$124M$153M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Inhibrx Biosciences, Inc.
CIK
0002007919
Tickers
INBX
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
La Jolla, California
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 19, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 19, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 14, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Apr 1, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 17, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 17, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 14, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 13, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 13, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jun 11, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jun 3, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jun 3, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed May 30, 2024 · filing
  • Change in control
    Form 8-K · items 1.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed May 30, 2024 · filing
  • Form 10 registration: Registration of a class of securities (Form 10)
    Form 10-12B · filed Apr 25, 2024 · filing